Recall Notices

warning

After notification of any recall, Express Scripts will continue processing new and refill prescriptions with product from non-recalled lots or manufacturers, if available. Please visit the U.S. Food and Drug Administration (FDA) website for the most up-to-date information on drug safety and recalls.

Panzyga Voluntary Withdrawal of One Lot
October 28, 2026
On Oct. 15, 2026, Octapharma USA, Inc. initiated a voluntary market withdrawal of one lot of Panzyga® (immune globulin intravenous, human-ifas) 10% liquid preparation.
Yimmuogo Voluntary Withdrawal of One Lot
October 28, 2026
On Oct. 7, 2026, Biotest AG initiated a voluntary withdrawal of one lot of Yimmugo® (immune globulin intravenous, human-dira) 10% liquid.
Sodium Chloride Injection Recalled
October 06, 2026
Otsuka ICU Medical initiated a voluntary recall of 0.9% Sodium Chloride Injection on Sept. 17, 2026
LubriFresh PM Nighttime Ointment Recalled
October 06, 2026
Sterling Pharmaceuticals initiated a recall of LubriFresh™ P.M. Nighttime Ointment (mineral oil 15%, white petrolatum 83%)
Lactated Ringer’s Injection Recalled
October 06, 2026
On Aug. 19, 2026, B. Braun Medical Inc. initiated a voluntary recall of Excel® Lactated Ringers injection, 1000mL
Product Correction for Actidose Products
October 06, 2026
On Sept. 1, 2026, Padagis US LLC issued a product correction for all lots of Actidose with Sorbitol, Actidose Aqua 50g and Actidose Aqua 15g
Exenatide Recalled
October 06, 2026
On Aug. 31, 2026, Amneal Pharmaceuticals LLC initiated a voluntary recall of exenatide injection, 250 mcg/mL
Sodium Chloride Injection Recalled
October 06, 2026
B. Braun Medical Inc. announced on Aug. 19, 2026, a voluntary nationwide recall of three lots of 0.9% Sodium Chloride Injection USP, 100mL, in a 150mL PAB® Container.
Sodium Chloride Injection Recalled
August 28, 2026
Baxter International Inc. announced on Aug. 25, 2026, a voluntary nationwide recall of 0.9% Sodium Chloride Injection 500mL VIAFLEX Plastic Container.
Thyroid Tablets Recalled
August 28, 2026
On Aug. 21, 2026, Vitruvias Therapeutics, Inc. initiated a voluntary recall for one lot of Thyroid Tablets, USP 30mg.

The information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.